SUFU promotes GLI activity in a Hedgehog-independent manner in pancreatic cancer

Brooke D Paradise1,2, Vladimir G Gainullin1, Luciana L Almada1

  • 1Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, MN 55905, U.S.A.

PubMed

Insights

Suppressor of Fused (SUFU) surprisingly promotes GLI activity in pancreatic ductal adenocarcinoma (PDAC). SUFU enhances GLI-driven BCL2 expression, impacting cancer cell viability and offering new insights into Hedgehog signaling in cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Aberrant activation of the Hedgehog (Hh) signaling pathway, involving GLI transcription factors (TF), is common in cancer.
  • Suppressor of Fused (SUFU) typically acts as a negative regulator of the Hh pathway, and its inactivation increases GLI activity.
  • Understanding novel regulatory mechanisms of Hh/GLI signaling is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the role of SUFU in regulating GLI activity in pancreatic ductal adenocarcinoma (PDAC).
  • To identify novel mechanisms of Hh/GLI pathway regulation in cancer cells.

Main Methods:

  • SUFU knockdown (KD) and overexpression in PDAC cells.
  • Array PCR analysis to identify GLI target genes.
  • GLI1-SUFU interaction studies and chromatin immunoprecipitation (ChIP) assays.
  • Assessment of cell viability and BCL2 rescue experiments.

Main Results:

  • SUFU overexpression increased GLI transcriptional activity in non-ciliated PDAC cells.
  • SUFU KD reduced GLI activity and BCL2 expression, leading to decreased PDAC cell viability.
  • Overexpression of BCL2 partially rescued the reduced cell viability caused by SUFU KD.
  • SUFU and GLI1 interact in the nucleus and bind to the BCL2 promoter, promoting GLI1 activity without affecting protein stability.

Conclusions:

  • SUFU acts as a novel promoter of GLI activity in PDAC, challenging its traditional role as solely a negative regulator.
  • SUFU positively regulates GLI1-driven BCL2 expression, impacting PDAC cell viability.
  • This study reveals a new mechanism of Hh/GLI signaling pathway regulation in cancer cells.

Related Concept Videos